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ARL3 Mutations Cause Joubert Syndrome
by Disrupting Ciliary Protein Composition
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Joubert syndrome (JBTS) is a genetically heterogeneous autosomal-recessive neurodevelopmental ciliopathy.We investigated further the
underlying genetic etiology of Joubert syndrome by studying two unrelated families in whom JBTS was not associated with pathogenic
variants in known JBTS-associated genes. Combined autozygosity mapping of both families highlighted a candidate locus on chromo-
some 10 (chr10: 101569997–109106128, UCSCGenome Browser hg 19), and exome sequencing revealed twomissense variants in ARL3
within the candidate locus. The encoded protein, ADP ribosylation factor-like GTPase 3 (ARL3), is a small GTP-binding protein that is
involved in directing lipid-modified proteins into the cilium in a GTP-dependent manner. Both missense variants replace the highly
conserved Arg149 residue, which we show to be necessary for the interaction with its guanine nucleotide exchange factor ARL13B,
such that the mutant protein is associated with reduced INPP5E and NPHP3 localization in cilia. We propose that ARL3 provides a po-
tential hub in the network of proteins implicated in ciliopathies, whereby perturbation of ARL3 leads to the mislocalization of multiple
ciliary proteins as a result of abnormal displacement of lipidated protein cargo.Mutations in genes that are involved in the structure or
function of the primary cilium give rise to a range of disor-
ders known as ciliopathies.1 These are typically multi-sys-
tem disorders, as seen in the archetypal ciliopathy Joubert
syndrome (JBTS), which is characterized clinically by brain
malformations that result in developmental delay, oculo-
motor apraxia, and hypotonia.2 In addition to the neuro-
developmental phenotype, retinal and renal diseases are
often associated with JBTS.3 Now more than 35 genes are
known to cause JBTS whenmutated in an autosomal-reces-
sive or X-linked manner4–7 (also see GeneReviews in Web
Resources). Genetic approaches have moved from tradi-
tional linkage studies and homozygosity mapping to
exome sequencing strategies, protein interaction net-
works,8 and genome-wide small interfering RNA screens,9
allowing a rapid rate of gene discovery. Despite these ad-
vancements, which made it possible for the majority of
JBTS cases to have a genetic diagnosis,10 many cases of
JBTS remain genetically unsolved, and critically, the in-
ter-relationships between the proteins encoded by these
genes and the underlying disease mechanisms remain
poorly understood. Here, we used a combination of
autozygosity mapping and whole-exome sequencing
(WES)11,12 in two unsolved JBTS-affected families and
identified likely deleterious variants in ARL3 (MIM:
60495). We further investigate the mechanistic impact of
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activity of ARL13B and causes associated defects in ciliary
proteins in affected individuals’ fibroblasts.
Family 1 is a Saudi Arabian family comprising first-
cousin healthy parents and six children, including the
5-year-old male index individual (II:5; Figure 1). His clin-
ical features include developmental delay, multicystic
dysplastic left kidney, night blindness, and mild dysmor-
phic features, including ptosis (Figure 1 and Table 1). Mag-
netic resonance imaging (MRI) of the brain showed severe
vermis hypoplasia with abnormal thick cerebellar pedun-
cles configured in the shape of a typical molar tooth sign
(Figure 1B), as well as abnormal configuration of the
midbrain, thinning of the pontomesencephalic junction
and midportion of the midbrain, and mild decreased brain
volume with a paucity of white matter in the frontotempo-
ral region and dilated ventricular system. This family is
part of a large ciliopathy cohort (enrolled in a research pro-
tocol approved by King Faisal Specialist Hospital and
Research Center research advisory council 2080006 after
providing informed consent). Family 2, originating from
Pakistan, is also consanguineous and comprises three
affected children with a clinical syndrome in keeping
with JBTS (II;1, II:4, and II:5; Table 1 and Figure 1). The
eldest sibling (II:1) presented with hypotonia and psycho-
motor delay. Subsequently, the child developed night
blindness and bilateral visual loss by 4 years of age. SheLife, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK; 2Department of
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Figure 1. Clinical and Radiological Images of the Affected Members of the Two Families Included in This Study
(A) A pedigree of the two families shows the number of affected siblings in each family and the outcome of segregation analysis (affected,
shaded; carriers, half-shaded; and WT, unshaded). The proband in each family is indicated by a black arrow. Genotypes for the proband
and their siblings are shown.
(B–E) BrainMRI of the four affected individuals (B, II:5 in family 1; C, D, and E, II:1, II:4, and II:5 in family 2) in this study shows evidence
of a molar tooth sign, cerebellar vermis hypoplasia, and elongation of the superior cerebellar peduncles (arrowed).
(F) Facial photo of the proband (II:5) in family 1 shows dysmorphic features (depressed nasal bridge, upturned nares, ptosis, arched eye-
brows, synophrys, telecanthus, and low-set ears).
(G and H) Ultrasound scan image of the kidneys of the affected member in family 1 (II:5) shows an echogenic left multicystic dysplastic
kidney (G) and an unaffected right kidney (H).
(I–R) Retinal imaging, including multicolor scanning laser fundal images of the eyes, of the three affected siblings in family 2 (II:1, II:4,
and II:5) shows granular alterations of the retinal pigment epithelium and subtle spicule formation, particularly around the major
vascular arcades, and arteriolar attenuation (I, II:1; J, II:4; K, II:5). Autofluorescence images show stippled hypo-autofluorescence areas
concentrated around the arcades (L, II:1) and hyper-autofluorescence around fovea (M, II:4; N, II:5). Horizontal optical coherence tomog-
raphy scans demonstrate thinning of the outer nuclear layer and loss of ellipsoid and external limiting membrane lines with preserva-
tion of inner retinal lamination in all three siblings (O, II:1; P, II:4; Q, II:5). A horizontal optical coherence tomography scan of a healthy
control individual is shown for comparison (R).also had recurrent urinary-tract infections (Table 1). Clin-
ical investigations revealed the molar tooth sign that is
typical of JBTS on brain MRI, as well as retinal dystrophy
(Figure 1). The other two affected siblings (II:4 and II:5)
had very similar presentations with predominating brain
and retinal features (Table 1 and Figure 1). Siblings II:1
and II:4 experienced problems with thermoregulation,
which implies brainstem involvement, as well as the
known cerebellar defects typical of JBTS. This family was
enrolled in a research protocol approved by the National
Research Ethics Service (09/H0903/36) after providing
informed consent.
Exome sequencing of the index individual in each fam-
ily and variant filtering were performed as previously
described.7 In brief, WES was performed with the TruSeq
Exome Enrichment Kit from Illumina. Coding and splicing
homozygous variants were considered as candidates only if
they were present within the candidate locus, had a fre-
quency < 0.1% in publicly available variant databases
(1000 Genomes, NHLBI Exome Sequencing Project
Exome Variant Server, and Genome Aggregation Database
[gnomAD]) and a database of in-house ethnically matched
exomes (Saudi Human Genome Program; totaling 2,379
exomes), and were predicted to be pathogenic in silico.The AmericaInterestingly, both families were flagged by the corre-
sponding research group because exome sequencing did
not reveal a likely deleterious bi-allelic variant in any of
the established JBTS-related genes. Through an investi-
gator-initiated collaboration, an attempt was made to
exploit the consanguineous nature of both families, which
can readily reveal a potentially unifying etiology if
they have an overlapping autozygome, as previously
described.7 Inbrief,weperformedgenome-wide genotyping
with theAxiomSNPChip platform fromAffymetrix and the
Sure Select V4 platform fromAgilent Technologies and then
determined autozygomes by using HomozygosityMapper
on all available family members. This revealed a single
critical locus (chr10: 101,569,997–109,106,128, UCSC
Genome Browser hg 19) (Figure 2A). This locus spans 57
genes, none of which is known to be linked to a ciliopathy
phenotype. After re-analyzing the exome variants by
only considering variants within this locus (Tables S1 and
S2), we found a single previously unreported variant in
ARL3 in each index individual: c.445C>T (p.Arg149Cys)
(GenBank: NM_004311.3) in family 1 and c.446G>A
(p.Arg149His) (GenBank: NM_004311.3) in family 2
(Figure 2B). Both homozygous variants fully co-segregated
with the JBTS phenotype in each family.n Journal of Human Genetics 103, 612–620, October 4, 2018 613
Table 1. Clinical Features of JBTS in Affected Family Members
Family 1 Family 2
II:5 II:1 II:4 II:5
Age (years) 5 21 12 9
Central nervous
symptoms
developmental delay,
ataxia
developmental delay,
ataxia
developmental delay,
ataxia
developmental delay,
ataxia
Ocular symptoms ptosis, rod-cone dystrophy,
night blindness,
bilateral visual pathway
involvement
rod-cone dystrophy,
night blindness,
progressive visual loss
rod-cone dystrophy,
night blindness, progressive
visual loss
rod-cone dystrophy, night
blindness, progressive visual
loss, oculomotor apraxia
eGFR (mL/min/1.73 m2) NA 75 >90 >90
Renal symptoms none recurrent UTI none recurrent UTI
USS renal left multicystic dysplastic
kidney, right grade I
hydronephrosis
bilateral renal scarring normal USS unequal kidney size
Other single palmar crease, pectus
carinatum, normal ABR
thermoregulation problems,
episode of transverse myelitis
thermoregulation problems,
sleep apnea
none
Abbreviations are as follows: ABR, auditory brainstem response; eGFR, estimated glomerular filtration rate; NA, not available; USS, ultrasound scan; and UTI, uri-
nary-tract infection.ARL3 is a highly conserved gene, and its encoded pro-
tein, the small G-protein ARL3, localizes to the cilium
and is crucial for ciliogenesis and axoneme formation, as
well as cargo displacement of lipidated proteins in the
cilium.13 ARL3 variants have also been reported in asso-
ciation with retinal dystrophy.14 Among ARL3 effectors
are the GDI-like solubilizing factors (GSFs) PDE6D,
UNC119A, and UNC119B, whose interactions are guano-
sine triphosphate (GTP) dependent. GSFs bind to and sol-
ubilize prenylated and myristoylated proteins, which are
released by ARL3-GTP acting as an allosteric release fac-
tor.15,16 The cilia-specific protein ARL13B acts as a specific
GEF for ARL3, whereas retinitis protein 2 (RP2) functions
as an ARL3 GTPase-activating protein (GAP) and is local-
ized in the pre-ciliary compartment.17,18 This segregation
of a GEF and a GAP is proposed to create an ARL3-GTP
gradient inside the cilium,19 which ensures the destina-
tion-specific release of lipid-modified ciliary proteins, solu-
bilized by GSFs.20
The ARL3 Arg149 residue is highly conserved
throughout evolution (Figure 2C), and in silico prediction
tools suggest that either missense change is likely to be
pathogenic (Table S3). Homology models of ARL3 reveal
that the two variants, which are located in a loop between
the a4 and b6 domains (Figure 3A), are predicted to
disrupt the interaction of ARL13B with ARL3 because it re-
quires this precise residue (Arg149) for its interaction
(Figure 3B). Superimposing all known structures of ARL3
in complex with its effectors, GAP and GEFS, the ARL3
Arg149 residue is exclusively present in the interface
between ARL3 and ARL13B and is involved in an ionic
interaction with the conserved ARL13B Glu88 residue
(Figure 3B). To functionally investigate the effect of
the mutation on the interaction with ARL13B, we per-
formed a GEF fluorescence-based polarization experi-614 The American Journal of Human Genetics 103, 612–620, Octobement.19 Wild-type (WT) and mutant p.Arg149His versions
of murine ARL3 (98.35% sequence identity to human
ARL3) were bound to fluorescently labeled GDP, and an
excess of unlabeled GTP was added in the presence or
absence of human ARL13B. We then followed the capa-
bility for nucleotide exchange of both versions of the pro-
tein by recording the fluorescence polarization over time.
Upon addition of the ARL13B GEF, WT ARL3 showed a
clear acceleration of nucleotide exchange. Under similar
conditions, mutant p.Arg149His ARL3 failed to show accel-
eration of nucleotide exchange in the presence of ARL13B
(Figure 3C). The integrity of the mutant protein was
confirmed by pull-down, whereby both WT and
p.Arg149His ARL3 proteins were pulled down equally by
UNC119A (Figure 3F and Figure S1). Furthermore, we
confirmed our results by using the highly conserved
C. reinhardtii ARL3 (WT and mutant p.Arg148His) and
ARL13B (Figure 3D). To further investigate the importance
of the ARL3-ARL13B interaction, we carried out the
reverse charge variant p.Glu86Arg in ARL13B by using
C. reinhardtii proteins. As expected, p.Glu86Arg ARL13B
was not able to accelerate the nucleotide exchange of WT
ARL3 (Figure 3E). From these experiments, we conclude
that p.Arg149His ARL3 disrupts the interaction with
ARL13B and is defective in ARL13B-assisted nucleotide
exchange.
To determine ciliary morphology, we obtained fibro-
blasts from all three affected individuals in family 2 (II:1,
II:4, and II:5) plus control individuals (both parents [I:1
and I:2] and an unaffected sibling [II:3]). Primary cilia iden-
tified by ARL13B antibodies were of normal length in
affected individuals (mean length ¼ 5.9, 7.8, and 6.8 mm
in II:1, II:4, and II:5, respectively) and control individuals
(mean length ¼ 5.7 and 6.0 mm in the parents and
6.1 mm in the unaffected sibling), and there were nor 4, 2018
Figure 2. Molecular Genetic Investigations of the Two JBTS-Affected Families
(A) Genome-wide homozygosity mapping shows the shared homozygous region between the affected members of the two families on
chromosome 10 (blue rectangle). Regions of homozygosity are shown in red, and the position of ARL3 is marked with a black arrow.
(B) Schematic representation to ARL3 with the homozygous missense variants located in exon 5.
(C) Evolutionary conservation of residue Arg149, which is highly conserved throughout all species shown except D. melanogaster.
(D) Sequence chromatograms of the two different ARL3 variants described in this study.significant differences between the two groups (Figure S2).
There was also no difference in the percentage of ciliation
rates between affected and control fibroblasts (Figure S2).
Scanning electron microscopy confirmed these findings
of no significant changes in cilia length or structural
appearance (Figure S3).
ARL3 functions as an allosteric release factor of all GSFs
members: PDE6D, UNC119A, and UNC119B. Whereas
PDE6D is involved in the trafficking of prenylated pro-
teins, UNC119A and UNC119B traffic myristoylated pro-
teins.19 Given that ARL3 exerts its releasing function
only when bound to GTP, we expected the ciliary localiza-
tion of the GSF cargo to be impaired. The INPP5E, GRK1,
and PDE6 catalytic subunits are among the prenylated
GSF ciliary cargo,20 whereas the myristoylated ciliary cargo
includes NPHP3, GNAT1, and Cystin1.22 To test our hy-
pothesis, we examined cilia for protein content of both
the prenylated INPP5E and myristoylated NPHP3. ARL3-
mutant cilia demonstrated a significant loss of both
INPP5E and NPHP3 content (Figure 4 and Figures S4–S6),
indicating that WT ARL3 is required for normal release of
these cargos into the ciliary axoneme. To confirm these
phenotypes as specific to the loss of ARL3 function, we
sought to determine the ciliary content of GLI3 in WT
and ARL3-mutant cilia. GLI3 translocation is independentThe Americaof GSF transport and relies upon intraflagellar transport
proteins and Sonic Hedgehog signal transduction.23
Consistent with morphologically normal cilia in ARL3-
mutant fibroblasts, no defect in ciliary GLI3 was observed
after stimulation with SAG, a Hedgehog pathway agonist.
The amounts of total ciliary GLI3 and ciliary tip GLI3
were unchanged between affected and control individuals
(Figure S7), confirming that the ciliary Hedgehog signaling
pathway is not disturbed by this particular ARL3mutation.
Together, these data substantiate a role for ARL3 in the
release of both prenylated and myristoylated ciliary cargo,
which is disrupted by the p.Arg149His ARL3 variant.
We present ARL3 as a ciliopathy- and JBTS-associated
gene. LdARL-3A, a Leishmania homolog of ARL3, is an
essential component of flagellum formation.24 Arl3 knock-
down has previously been investigated in a gene-trap mu-
rine model, where Arl3 was disrupted after the first exon.25
These Arl3/ mice, which represent a null allele, devel-
oped a severe ciliopathy phenotype with pronounced
cystic kidney disease, pancreatic hypoplasia, ductal plate
malformation within the liver, and retinal dystrophy
with impaired photoreceptor development.25 The mice
died within 3 weeks of age, indicating a severe phenotype,
which is much more detrimental than that of our human
subjects, who carry a missense mutation. We speculaten Journal of Human Genetics 103, 612–620, October 4, 2018 615
Figure 3. The Human ARL13B-ARL3
Complex Is Predicted to Involve an Inter-
action between Evolutionarily Conserved
Glutamate and Arginine Residues
(A) Partial amino acid sequence alignments
of the ciliary GEF, ARL13B, and ARL3.
Highlighted in red are the evolution-
arily conserved glutamate residue located
in the switch II domain of ARL13B
(E86 [Glu86] in C. reinhardtii ARL13B
[CrARL13B]) and the arginine residue in
the loop region between the a4 and b6 do-
mains of ARL3 (R148 [Arg148] in CrARL3).
(B) Superimposition of the crystal struc-
tures of ARL3 (gray) in complex with
its known interactors: the effectors
UNC119A (salmon; PDB: 4GOJ15) and
BARTL1 (yellow; PDB: 4ZI221), the GAP
RP2 (orange; PDB: 3BH617), and GEF
ARL13B (blue; PDB: 5DI319). On the right
side is a zoomed-in view of the salt
bridge between Glu86 and Arg148 at the
CrARL13B-CrARL3 complex interface.
(C) Assay of GEF activity for murine WT
ARL3 (ARL3WT) and p.Arg149His ARL3
(ARL3R149H). Fluorescence polarization
was measured for 1 mM mantGDP-loaded
ARL3, to which 400 mM GppNHp and
5 mM H. sapiens ARL13B (HsARL13B) were
added. Nucleotide exchange was shown
by only ARL3WT.
(D) Assay of GEF activity with fluores-
cence polarization measurements of
0.5 mM mantGDP-loaded CrARL3WT and
CrARL3R148H, to which 10 mM GppNHp
(GTP analog) and 5 mM CrARL13B$
GppNHp were added at the indicated
time points. Only CrARL3WT showed
nucleotide exchange, as indicated by the
drop in fluorescence polarization.
(E) Assay of GEF activity with fluorescence
polarization measurements of 0.5 mM
mantGDP-loaded CrARL3WT and 5 mM
CrARL13B$GppNHpWT or CrArl13bE86R, to
which 10 mM GppNHp (GTP analog) was
added at the indicated time points. Only
CrArl13bWT showed nucleotide exchange, as indicated by the drop in fluorescence polarization.
(F) 30 mg of full-length UNC119A-GST was used to pull down 60 mg of murine ARL3WT and ARL3R149H that were loaded with the GTP
analog GppNHp. Proteins were detected on immunoblots with anti-GST (red) and anti-His (green) antibodies.that nonsense mutations in ARL3 in humans could cause
more pronounced ciliopathy phenotypes, such as the peri-
natally lethal ciliopathy Meckel syndrome,26 and could go
some way to explaining why such a fundamental gene has
previously not been identified in ciliopathy syndromes. It
is noteworthy that the ExAC Browser and gnomAD do
not have any homozygous pathogenic variants reported
within ARL3 and that the gene is relatively intolerant to
variation (positive Z score of 0.44). We did not identify
any additional ARL3 pathogenic variants in our WES data-
bases, which are relatively enriched with autozygosity, or
in a cohort of 35 unsolved JBTS-affected individuals.
In humans, Strom et al. previously reported the hetero-
zygous missense variant c.269A>G (p.Tyr90Cys) in ARL3
in a European-descent pedigree with non-syndromic reti-
nitis pigmentosa.27 The variant, which was rare, appeared616 The American Journal of Human Genetics 103, 612–620, Octobede novo and was predicted to be pathogenic, was confirmed
as heterozygous in three affected individuals, and was
transmitted in an autosomal-dominant fashion. A second
allele was not identified, and mechanistic evaluation was
not carried out. On the other hand, here we have identified
bi-allelic ARL3 changes that fully segregate with a clas-
sical JBTS phenotype, including retinal changes. Thus,
although the connection between the de novo ARL3 variant
and retinitis pigmentosa remains unexplained, it seems
that bi-allelic ARL3 deleterious variants are sufficient to
cause JBTS. The involvement of ciliopathy-associated
genes in non-syndromic retinitis pigmentosa has been
well described, so it would be of interest for the affected in-
dividual reported by Strom et al. to be investigated for the
possibility of a second deleterious allele in trans in ARL3. It
is also possible that, as reported here, bi-allelic mutationsr 4, 2018
Figure 4. Characterization of Ciliary Phenotype in ARL3-Mutant Fibroblasts from Family 2
(A and C) Affected and control fibroblasts were observed under high-power immunofluorescence for determining ciliary expression of
(A) INPP5E and (C) NPHP3. Cilia were localized with anti-ARL13B (red) and anti-PERICENTRIN (magenta) for the identification of the
ciliary membrane and the base of cilia, respectively. Scale bars, 10 mm.
(B) Quantification of ciliary localization of INPP5E (**p < 0.0001, unpaired t test, n > 150 cilia for each group). Total cilia INPP5E in
control fibroblast (II:3) cilia is higher than in heterozygous fibroblast (I:1 and II:2) cilia.
(D) Quantification of ciliary localization of NPHP3 (**p < 0.0001, unpaired t test, n > 150 cilia for each group).inARL3 give rise to an extended phenotype compared with
its reported dominant phenotype. A growing number of
genes are known to cause distinct phenotypes according
to whether dominant or recessive variants are inherited.
For retinitis pigmentosa, mutations (typically nonsense)
in RP1 were initially described in an autosomal-dominant
pattern,28 followed by autosomal-recessive (homozygous
missense) variants.29 For Gillespie syndrome, a form
of non-progressive cerebellar ataxia, both bi-allelic and
mono-allelic mutations in ITPR1 (MIM: 147265) have
been reported,30 and the single heterozygous mutations
were thought to exert a dominant-negative effect. In addi-
tion, variants in genes known only to be related to auto-
somal-dominant disease have been found in association
with recessive mutations, both where the phenotypes
are similar but more severe (ACTG2-related visceral myop-
athy [MIM: 102545]) and where distinctly different pheno-
types have been observed (FBN2-related myopathy [MIM:
612570] and CSF1R-related brain malformation [MIM:
164770]).31
Interestingly, pathogenic variants in the ARL3 interac-
tion partners ARL13B and PDE6D also cause JBTS.
ARL13B (MIM: 608922) mutations were reported in indi-
viduals with a classical neurodevelopmental JBTS pheno-
type (JBTS8) without prominent renal phenotypes.32 It is
particularly noteworthy that some affected individuals
had a small occipital encephalocele, indicating that more
severe brain phenotypes could be likely. PDE6D (MIM:
602676) mutations have been reported in three siblings
with JBTS (JBTS22) and associated retinal and post-axial
polydactyly phenotypes, as well as kidney hypoplasia.33
Furthermore, the disrupted ciliary cargo proteins (INPP5E
and NPHP3) we identified are also responsible for JBTS
phenotypes when their encoding genes are mutated.
INPP5E (MIM: 613037) mutations cause JBTS1 and were
identified in a cohort of JBTS-affected individuals withThe Americamainly neurological features and some retinopathy but
without kidney disease or polydactyly,34 suggesting a lack
of Hedgehog signaling defects.35,36 In contrast, NPHP3
(MIM: 608002) mutations were initially identified as
causing an adolescent form of nephronophthisis, a pro-
gressive form of renal failure.37 Since this initial report,
NPHP3 mutations have been associated with a wider spec-
trum of disease, including infantile nephronophthisis (re-
sulting in end-stage renal failure before 5 years of age38)
and Meckel syndrome.39 The full spectrum of disease phe-
notypes secondary to ARL3mutation therefore remains to
be determined, but ARL3 is widely expressed and funda-
mental to the ciliary localization of a wide range of pro-
teins. Therefore, one could predict that any severity of
JBTS disease with retinal and renal involvement is possible.
It will be important to study the tissue-specific roles of
ARL3 and the implications of disrupting expression in
these tissues.
The primary cilium exerts its function by concentrating
certain proteins and lipids, thereby maintaining a distinct
composition and function. ARL13B is specifically localized
in the cilium, creating a high ciliary concentration of
ARL3-GTP, which in turn produces a hotspot for releasing
GSF-bound cargo. Our study underscores the physiological
importance of this mechanism because the human muta-
tion we characterize, c.446G>A (p.Arg149His), disrupts
the interaction between ARL13B and ARL3 and results in
loss of GSF cargo concentration in the cilia (Figure 5). As
we have described, ciliopathies such as JBTS show overlap-
ping phenotypes, and one gene can be involved in a broad
range of ciliopathy phenotypes. A cause of this overlap is
most likely the fact that proteins do not work in isolation
but in networks. Indeed, it has been shown that ciliopathy-
associated proteins form different modules that cross talk
and interact together.8,40 Through the identification of
ARL3 variants as a cause of JBTS, we show that ARL3n Journal of Human Genetics 103, 612–620, October 4, 2018 617
Figure 5. Model of GSF-Cargo Release in Cilia with WT ARL3
versus p.Arg149 ARL3 Missense Variants
ARL13B assists ARL3 in cilia to exchange its bound GDP to GTP.
The specific localization of ARL13B in the cilia creates a high con-
centration of ARL3-GTP. ARL3-GTP in turn can release the cargo
bound to its cognate GSF, resulting in ciliary localization. Missense
variants of ARL3 (including p.Arg149His and p.Arg149Cys) are not
able to interact with ARL13B, and the ARL3GTP concentration is
therefore low in the cilia, resulting in inefficient release of GSF
cargo in the cilia.provides a hub within the network of ciliopathy-associated
genes, whereby perturbation of ARL3 results in the misloc-
alization of multiple ciliary proteins, including INPP5E
and NPHP3. Our mechanistic model might provide good
starting points for therapeutic intervention where small
molecules can be used to release GSF-bound cargo and
compensate for the loss of ARL3 release activity. Direct-
ing such therapies to the kidney in individuals with
JBTS-associated renal dysfunction and to the retina in cases
of progressive visual loss secondary to JBTS would be desir-
able. Using small molecules to disrupt GSF-cargo interac-
tion has been reported,41,42 and it will be important to
test those small molecules with regard to cilia function
and their application in ciliopathies. Nevertheless, a chal-
lenge will be to target these small molecules specifically
to the cilia, where the function of ARL3 is concentrated,
to assure the correct targeting of ciliary GSF cargo.
In conclusion, we have identified ARL3 missense vari-
ants as a likely cause of JBTS. On the basis of limited obser-
vations, the phenotype related to variants in this gene
seem to be a cerebello-retinal presentation similar to that
caused, for instance, by pathogenic variants in AHI1
(MIM: 608894).43,44 In fact, none of the affected individ-
uals presented with any striking additional features, and
renal involvement was inconstant. Because effective treat-
ments for JBTS are lacking at present, genotype-phenotype
correlations could prove useful in giving prognostic indica-
tions to families. We have shown that substitution of argi-
nine at position 149 disrupts the known interaction be-
tween ARL3 and ARL13B and thus prevents the correct
release of intra-ciliary cargos, including INPP5E and
NPHP3. Furthermore, we propose that therapeutic manip-618 The American Journal of Human Genetics 103, 612–620, Octobeulation of ciliary cargo release could provide an innovative
treatmentmechanism for human ciliopathies such as JBTS.Accession Numbers
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